MARKET

NXSCF

NXSCF

Next Science
OTCPK
0.015
NaN%
Closed 09:30 02/06 EST
OPEN
--
PREV CLOSE
0.015
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.060
52 WEEK LOW
0.010
MARKET CAP
4.39M
P/E (TTM)
-0.4658
1D
5D
1M
3M
1Y
5Y
1D
Next Science Amends Payment Date for Approved Capital Return
TipRanks · 6d ago
Next Science Pushes Back Capital Return Payment as It Nears ASX Exit
TipRanks · 01/30 09:21
Next Science to Return Cash Capital to Shareholders Following Approval
TipRanks · 01/28 04:17
Next Science Investors Back Capital Return and ASX Delisting
TipRanks · 01/28 00:37
Next Science Details Cash Position and Capital Return Plan After Asset Sale
TipRanks · 01/27 22:49
Next Science Director Harry Thomas Hall IV Steps Down but Retains Shareholding
TipRanks · 01/07 05:37
ASX Suspends Next Science Shares Over Insufficient Operations
TipRanks · 01/01 23:47
Next Science Sets Capital Return, Delisting Plan as CEO and CFO Resign
TipRanks · 12/23/2025 06:58
More
About NXSCF
Next Science Limited is an Australia-based medical technology company. The Company focuses on enhancing patient outcomes, empowering physicians, and driving healthcare innovation through education, research, and cutting-edge product development. Its Durable Medical Equipment (DME) Wound Care includes advanced wound care solutions delivered through partnerships with DME providers, particularly in the United States home health and outpatient settings.

Webull offers Next Science Ltd stock information, including OTCPK: NXSCF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NXSCF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NXSCF stock methods without spending real money on the virtual paper trading platform.